معرفی
Samuli Ripatti is a Professor of Biometry at the Faculty of Medicine, University of Helsinki, and Director of the Institute for Molecular Medicine Finland (FIMM). He chairs the Research Council Finland’s Centre of Excellence in Complex Disease Genetics and the EU H2020-funded Intervene Consortium. His research focuses on genetic variation in the Finnish population, particularly its effects on cardiometabolic diseases and cancers, with a strong emphasis on polygenic risk scores for disease prevention and early detection.
His work spans
- Genetic risk prediction models
- Lipidomic and metabolomic profiling
- Gene-environment interactions
- Translational genomics
Recent research highlights include
- 1099 plasma metabolite-disease causal analysis
- Genetic determinants of weight loss interventions
- Cardiovascular risk stratification tools
- Leukocyte lipid metabolism pathways
He actively supervises doctoral programs in Integrative Life Science, Social Sciences, Clinical Research, and Population Health, and collaborates with the Broad Institute of MIT and Harvard.
